Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration
British Journal of Ophthalmology · 2025-08 · 109 (8) · 875-881
DOI: 10.1136/bjo-2024-326152 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Ophthalmology, online erschienen am 23.03.2025. Verfasst von Enrico Borrelli und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, University of Turin, Torino, Italy borrelli.enrico@yahoo.com. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Wet Macular Degeneration, Ranibizumab. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
To explore the factors and frequency of interruptions in intravitreal treatment for patients with neovascular age-related macular degeneration (AMD) and to evaluate the demographic and clinical factors linked to the reasons for discontinuation.
Methods
In this multicentre study, patients who began anti-vascular endothelial growth factor (VEGF) treatment between January 2019 and December 2021 for treatment-naïve neovascular exudative AMD were retrospectively analysed. The overall incidence of treatment discontinuation, along with the rates for each specific cause, was calculated. The probability of each cause of discontinuation over time from the start of treatment, as well as the risk factors associated with each case, was also determined.
Results
655 individuals (28.5%) discontinued intravitreal anti-VEGF therapy. Among the five main categories of causes for discontinuation (patient’s decision against clinician’s advice, continuation of therapy at another clinic, clinical decision, systemic diseases or death), clinical decision emerged as the most common reason for interruption. The qualitative evaluation of the Kaplan–Meier curves suggests a higher frequency of the clinical decision as a cause of discontinuation within the initial 2 years of treatment. Worse visual acuity increased the risk of discontinuation due to clinical decisions. Younger patients were more likely to stop anti-VEGF therapy by choice. Better visual acuity and longer distance from the clinic increased the likelihood of patients continuing treatment elsewhere.
Conclusions
The discontinuation of anti-VEGF treatment is common among individuals with neovascular AMD. Causes of discontinuation include not only clinician decisions but also those related to the patient’s health and personal choices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Sciences, University of Turin, Torino, Italy borrelli.enrico@yahoo.com.
- Department of Ophthalmology, "City of Health and Science" Hospital, Turin, Italy.
- Department of Surgical Sciences, University of Turin, Torino, Italy.
- Department of Human Sciences and Promotion of the Quality of Life, San Raffaele, Rome, Italy.
- Unit of Clinical and Molecular Epidemiology IRCCS San Raffaele Roma, Rome, Italy.
- Dept. of Ophthalmology, University Vita Salute Hospital San Raffaele, Milano, Italy.
Zitieren
APA
Borrelli, E., Foti, C., Ulla, L., Porreca, A., Introini, U., Grassi, M. O., Viggiano, P., Peronetti, M., Toscani, R., Boscia, G., Termite, A. C., Gennaro, C., Marolo, P., Boscia, F., Bandello, F., & Reibaldi, M. (2025). Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration. British Journal of Ophthalmology, 109(8), 875-881. https://doi.org/10.1136/bjo-2024-326152
Vancouver
Borrelli E, Foti C, Ulla L, Porreca A, Introini U, Grassi MO, et al. Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration. British Journal of Ophthalmology. 2025;109(8):875-881. doi:10.1136/bjo-2024-326152
BibTeX
@article{Borrelli2025,
author = {Borrelli, Enrico and Foti, Claudio and Ulla, Lorena and Porreca, Annamaria and Introini, Ugo and Grassi, Maria Oliva and Viggiano, Pasquale and Peronetti, Mario and Toscani, Rebecca and Boscia, Giacomo and Termite, Alba Chiara and Gennaro, Carlo and Marolo, Paola and Boscia, Francesco and Bandello, Francesco and Reibaldi, Michele},
title = {Incidence and reasons for discontinuation of anti-VEGF treatment in neovascular age-related macular degeneration},
journal = {British Journal of Ophthalmology},
year = {2025},
volume = {109},
number = {8},
pages = {875--881},
doi = {10.1136/bjo-2024-326152}
}
EUVIMED